Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Role of oestrogen receptors in bladder cancer development.

Hsu I, Vitkus S, Da J, Yeh S.

Nat Rev Urol. 2013 Jun;10(6):317-26. doi: 10.1038/nrurol.2013.53. Epub 2013 Apr 16. Review.

PMID:
23588401
2.

The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.

Bonkhoff H, Berges R.

Eur Urol. 2009 Mar;55(3):533-42. doi: 10.1016/j.eururo.2008.10.035. Epub 2008 Nov 6. Review.

PMID:
19013008
3.

Estrogen receptors: therapies targeted to receptor subtypes.

Nilsson S, Gustafsson JÅ.

Clin Pharmacol Ther. 2011 Jan;89(1):44-55. doi: 10.1038/clpt.2010.226. Epub 2010 Dec 1. Review.

PMID:
21124311
4.

Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues.

Morani A, Warner M, Gustafsson JA.

J Intern Med. 2008 Aug;264(2):128-42. doi: 10.1111/j.1365-2796.2008.01976.x. Epub 2008 May 29. Review.

5.
6.

Plasma membrane estrogen receptors.

Levin ER.

Trends Endocrinol Metab. 2009 Dec;20(10):477-82. doi: 10.1016/j.tem.2009.06.009. Epub 2009 Sep 23. Review.

7.

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.

Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.

J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. Review.

PMID:
11162936
8.

The different roles of ER subtypes in cancer biology and therapy.

Thomas C, Gustafsson JÅ.

Nat Rev Cancer. 2011 Jul 22;11(8):597-608. doi: 10.1038/nrc3093. Review.

PMID:
21779010
9.

Development of subtype-selective oestrogen receptor-based therapeutics.

Nilsson S, Koehler KF, Gustafsson JÅ.

Nat Rev Drug Discov. 2011 Sep 16;10(10):778-92. doi: 10.1038/nrd3551. Review.

PMID:
21921919
10.

ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis.

Meyer MR, Barton M.

Cardiovasc Res. 2009 Sep 1;83(4):605-10. doi: 10.1093/cvr/cvp187. Epub 2009 Jun 18. Review. No abstract available.

PMID:
19541668
11.

Estrogen receptor α and β in the normal immune system and in lymphoid malignancies.

Yakimchuk K, Jondal M, Okret S.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):121-9. doi: 10.1016/j.mce.2013.05.016. Epub 2013 May 23. Review.

PMID:
23707618
12.

Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.

Godoy G, Gakis G, Smith CL, Fahmy O.

Bladder Cancer. 2016 Apr 27;2(2):127-137. Review.

13.

Is oestrogen an important player in melanoma progression?

Janik ME, Bełkot K, Przybyło M.

Contemp Oncol (Pozn). 2014;18(5):302-6. doi: 10.5114/wo.2014.43938. Epub 2014 Nov 5. Review.

Supplemental Content

Support Center